Lipitor (Atorvastatin) News and Research

RSS
Atorvastatin (INN) (Lipitor, Pfizer), is a member of the drug class known as statins, used for lowering blood cholesterol. It also stabilizes plaque and prevents strokes through anti-inflammatory and other mechanisms. Atorvastatin inhibits HMG-CoA reductase, the rate-determining enzyme located in hepatic tissue that produces mevalonate, a small molecule used in the synthesis of cholesterol and other mevalonate derivatives. This lowers the amount of cholesterol produced which in turn lowers the total amount of LDL cholesterol. Atorvastatin was first synthesized in 1985 by Bruce Roth while working at Parke-Davis Warner-Lambert Company (now Pfizer). With 2006 sales of US$12.9 billion, Lipitor is the largest-selling drug in the world.
Cholesterol-lowering statin products may be the next class of drugs to go over the counter

Cholesterol-lowering statin products may be the next class of drugs to go over the counter

New ways to fight type 2 diabetes

New ways to fight type 2 diabetes

Liptor helps Alzheimer’s disease

Liptor helps Alzheimer’s disease

'Medicare-Approved' cards available soon

'Medicare-Approved' cards available soon

Pfizer's files lawsuit against unapproved copy of cholesterol drug Lipitor

Pfizer's files lawsuit against unapproved copy of cholesterol drug Lipitor

Medicare to launch website showing comparative drug pricing

Medicare to launch website showing comparative drug pricing

Research shows that intense high dose cholesterol lowering drugs result in a major reduction in deaths and severe heart attacks

Research shows that intense high dose cholesterol lowering drugs result in a major reduction in deaths and severe heart attacks

Largest marketing campaign for a single drug to date

Largest marketing campaign for a single drug to date